Zevra Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Zevra Therapeutics, Inc. (ZVRA) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$2.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- Zevra Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$149.00K, a 125.60% decline year-over-year.
- Zevra Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$2.05M.
- Zevra Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$399.00K, a 122.47% decline year-over-year.
- Zevra Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $3.05M.
- Zevra Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.94M, a 32.09% increase from fiscal 2024.
- Zevra Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.23M.
- Zevra Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$152.00K, a 117.00% decline from fiscal 2022.
- Zevra Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $894.00K, a 8.36% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$149.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.20M 10-Q · filed 2026-08-05 | -$2.60M derived: sum of 3 quarters · filed 2026-08-05 | $445.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$2.05M 10-Q · filed 2026-05-06 | -$2.45M derived: sum of 2 quarters · filed 2026-05-06 | $594.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.18M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.65M derived: sum of 2 quarters · filed 2026-03-09 | $3.23M derived: sum of 3 quarters · filed 2026-08-05 | $2.94M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $3.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.63M derived: sum of 2 quarters · filed 2026-08-05 | $3.34M 10-Q · filed 2025-11-05 | $5.12M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $582.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $296.00K 10-Q · filed 2026-08-05 | $2.07M derived: sum of 3 quarters · filed 2026-08-05 | $1.66M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$286.00K 10-Q · filed 2026-05-06 | $1.49M derived: sum of 2 quarters · filed 2026-05-06 | $1.08M derived: sum of 3 quarters · filed 2026-05-06 | $1.90M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.37M derived: sum of 2 quarters · filed 2026-03-09 | $2.18M derived: sum of 3 quarters · filed 2026-03-09 | $2.23M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$410.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $408.00K derived: sum of 2 quarters · filed 2025-11-05 | $452.00K 10-Q · filed 2025-11-05 | $327.00K derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $818.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $862.00K 10-Q · filed 2025-08-12 | $737.00K derived: sum of 3 quarters · filed 2025-08-12 | $375.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $44.00K 10-Q · filed 2025-05-13 | -$81.00K derived: sum of 2 quarters · filed 2025-05-13 | -$443.00K derived: sum of 3 quarters · filed 2025-05-13 | $595.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$487.00K derived: sum of 2 quarters · filed 2025-03-12 | $551.00K derived: sum of 3 quarters · filed 2025-03-12 | -$152.00K 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | -$362.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $676.00K derived: sum of 2 quarters · filed 2024-11-13 | -$27.00K 10-Q · filed 2024-11-13 | -$216.00K 10-Q · filed 2023-11-07 | -$329.00K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $335.00K 10-Q · filed 2024-08-14 | $146.00K 10-Q · filed 2023-08-14 | $33.00K derived: sum of 3 quarters · filed 2024-08-14 | -$663.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$703.00K 10-Q · filed 2024-05-09 | -$1.00M derived: sum of 2 quarters · filed 2024-05-09 | -$1.70M derived: sum of 3 quarters · filed 2024-05-09 | $494.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$998.00K derived: sum of 2 quarters · filed 2024-04-01 | $1.20M derived: sum of 3 quarters · filed 2024-04-01 | $894.00K 10-K · filed 2024-04-01 | $657.00K 10-K · filed 2023-03-07 | |||
| 2022-09-30 | -$696.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.50M derived: sum of 2 quarters · filed 2023-11-07 | $1.20M 10-Q · filed 2023-11-07 | $655.00K derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.89M 10-Q · filed 2023-08-14 | $1.35M derived: sum of 3 quarters · filed 2023-08-14 | $1.39M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$303.00K 10-Q · filed 2023-05-15 | -$844.00K derived: sum of 2 quarters · filed 2023-05-15 | -$808.00K derived: sum of 3 quarters · filed 2023-05-15 | $795.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$505.00K derived: sum of 2 quarters · filed 2023-03-07 | $1.10M derived: sum of 3 quarters · filed 2023-03-07 | $825.00K 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.64M derived: sum of 2 quarters · filed 2022-11-10 | $1.37M 10-Q · filed 2022-11-10 | $1.74M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.33M 10-Q · filed 2022-08-12 | $1.71M derived: sum of 3 quarters · filed 2022-08-12 | $1.69M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$273.00K 10-Q · filed 2022-05-12 | $104.00K derived: sum of 2 quarters · filed 2022-05-12 | $87.00K derived: sum of 3 quarters · filed 2022-05-12 | $22.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $360.00K derived: sum of 2 quarters · filed 2022-03-31 | $295.00K derived: sum of 3 quarters · filed 2022-03-31 | -$160.00K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$82.00K derived: sum of 2 quarters · filed 2021-11-10 | -$537.00K 10-Q · filed 2021-11-10 | $339.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$520.00K 10-Q · filed 2021-08-13 | $356.00K derived: sum of 3 quarters · filed 2021-08-13 | -$297.00K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$455.00K 10-Q · filed 2021-05-14 | $421.00K derived: sum of 2 quarters · filed 2021-05-14 | -$232.00K derived: sum of 3 quarters · filed 2021-05-14 | -$793.00K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $876.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $223.00K derived: sum of 2 quarters · filed 2021-03-12 | -$338.00K derived: sum of 3 quarters · filed 2021-03-12 | -$544.00K 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | -$653.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$1.21M derived: sum of 2 quarters · filed 2020-10-30 | -$1.42M 10-Q · filed 2020-10-30 | -$1.83M derived: sum of 4 quarters · filed 2020-10-30 | ||||
| 2019-06-30 | -$561.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$767.00K 10-Q · filed 2020-08-12 | -$734.00K 10-Q · filed 2019-08-13 | -$1.18M derived: sum of 3 quarters · filed 2020-08-12 | -$1.25M derived: sum of 4 quarters · filed 2020-08-12 | |||
| 2019-03-31 | -$206.00K 10-Q · filed 2020-05-13 | -$186.00K 10-Q · filed 2019-05-14 | -$618.00K derived: sum of 2 quarters · filed 2020-05-13 | -$688.00K derived: sum of 3 quarters · filed 2020-05-13 | -$1.31M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | -$412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$482.00K derived: sum of 2 quarters · filed 2020-02-28 | -$1.10M derived: sum of 3 quarters · filed 2020-02-28 | $548.00K 10-K · filed 2020-02-28 | ||||
| 2018-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$690.00K derived: sum of 2 quarters · filed 2019-11-14 | $960.00K 10-Q · filed 2019-11-14 | $1.05M 10-Q · filed 2018-11-09 | $1.16M derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | -$620.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $1.03M 10-Q · filed 2019-08-13 | $1.23M derived: sum of 3 quarters · filed 2019-08-13 | $1.80M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $1.65M 10-Q · filed 2019-05-14 | $1.85M derived: sum of 2 quarters · filed 2019-05-14 | $2.42M derived: sum of 3 quarters · filed 2019-05-14 | $2.37M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $775.00K derived: sum of 2 quarters · filed 2019-03-01 | $720.00K derived: sum of 3 quarters · filed 2019-03-01 | $926.00K 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $517.00K derived: sum of 2 quarters · filed 2018-11-09 | $723.00K 10-Q · filed 2018-11-09 | $504.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $151.00K 10-Q · filed 2018-08-10 | -$68.00K derived: sum of 3 quarters · filed 2018-08-10 | $65.00K derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $206.00K 10-Q · filed 2018-05-11 | -$13.00K derived: sum of 2 quarters · filed 2018-05-11 | $120.00K derived: sum of 3 quarters · filed 2018-05-11 | $560.00K derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | -$219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$86.00K derived: sum of 2 quarters · filed 2018-03-30 | $354.00K derived: sum of 3 quarters · filed 2018-03-30 | -$2.02M 10-K · filed 2018-03-30 | ||||
| 2016-09-30 | $133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $573.00K derived: sum of 2 quarters · filed 2017-11-09 | -$1.80M 10-Q · filed 2017-11-09 | -$2.16M 10-Q · filed 2016-11-10 | -$1.15M derived: sum of 4 quarters · filed 2018-03-30 | |||
| 2016-06-30 | $440.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$1.93M 10-Q · filed 2017-08-10 | -$1.93M 10-Q · filed 2016-08-11 | -$1.28M derived: sum of 3 quarters · filed 2018-03-30 | $272.00K derived: sum of 4 quarters · filed 2018-03-30 | |||
| 2016-03-31 | -$2.37M 10-Q · filed 2017-05-22 | -$1.72M derived: sum of 2 quarters · filed 2018-03-30 | -$168.00K derived: sum of 3 quarters · filed 2018-03-30 | -$1.17M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2015-12-31 | $652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $2.20M derived: sum of 2 quarters · filed 2018-03-30 | $1.20M derived: sum of 3 quarters · filed 2018-03-30 | $1.23M 10-K · filed 2018-03-30 | ||||
| 2015-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $546.00K derived: sum of 2 quarters · filed 2016-11-10 | $576.00K 10-Q · filed 2016-11-10 | -$483.00K derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$976.00K 10-Q · filed 2016-08-11 | -$2.04M derived: sum of 3 quarters · filed 2017-03-10 | -$1.46M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | $30.00K 10-Q · filed 2016-05-13 | -$1.03M derived: sum of 2 quarters · filed 2017-03-10 | -$454.00K derived: sum of 3 quarters · filed 2017-03-10 | -$447.00K derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$484.00K derived: sum of 2 quarters · filed 2017-03-10 | -$477.00K derived: sum of 3 quarters · filed 2017-03-10 | -$523.00K 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | $575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $582.00K derived: sum of 2 quarters · filed 2015-11-13 | $536.00K 10-Q · filed 2015-11-13 | |||||
| 2014-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$39.00K 10-Q · filed 2015-08-14 | ||||||
| 2014-03-31 | -$46.00K 10-Q · filed 2015-05-29 | |||||||
| 2013-12-31 | $4.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |